Cornish Eric R, Zheng Huiyong, Markel David C, Hallstrom Brian R, Hughes Richard E
MyMichigan Health, Alpena, MI, USA.
Department of Orthopedic Surgery, University of Michigan, Ann Arbor, MI, USA.
Acta Orthop. 2025 Aug 5;96:587-594. doi: 10.2340/17453674.2025.44250.
Arthroplasty registries report revision risk, but patient-reported outcomes may also measure implant performance. We aimed to evaluate (i) change in patient-reported outcome measures (PROMs) across multiple total knee arthroplasty (TKA) designs in a regional registry, (ii) the association of patellar resurfacing on the change in PROMs, and (iii) the variation in PROMs change within implants with or without patellar resurfacing.
This is a cohort of primary TKAs from Michigan Arthroplasty Registry Collaborative Quality Initiative (MARCQI) performed between January 1, 2017 and September 30, 2021. The dependent measure was change in KOOS JR. Independent variables were implant name and patellar resurfacing. Multivariate modeling adjusted for patient-level factors. A previous report suggests a change of 23 points in KOOS JR as clinically relevant in achieving acceptable pain/function levels. A clinically relevance ratio (CRR) of those achieving the threshold of 23 points to the overall group was calculated for each implant.
18 implant designs met the inclusion criteria. There were 51,606 cases with complete preoperative and postoperative KOOS JR matched pairs. There was variation in improvement from preoperative to postoperative unadjusted KOOS JR scores across implant designs (P < 0.001), ranging from 18.7 (95% confidence interval [CI] 16.8-20.6) to 27.0 (CI 24.9-29.2). Patellar resurfacing resulted in greater KOOS JR improvement 1.0 (CI 0.5-1.5, P < 0.001). Of the cases with resurfaced patellae, the CRR was 50.2% (CI 49.7-50.7). For cases without resurfaced patellae, the CRR was 47.2% (CI 45.9-48.5). The association of implant design persisted whether the patella was resurfaced or not, evident in the adjusted mean change in KOOS JR (P < 0.001), ranging from 20.1 (CI 17.6-22.6) to 25.5 (CI 24.3-26.7) for resurfaced and from 17.0 (CI 13.9-20.1) to 23.3 (CI 20.3-26.2) for not resurfaced, and the CRR difference (P < 0.001), ranging from 45.8% (CI 42.5-48.6) to 55.8% (CI 50.4-60.8) for resurfaced and from 37.9% (CI 27.4-44.7) to 51.4% (CI 43.9-56.6) for not resurfaced.
Implant design and patellar resurfacing both show an association with KOOS JR improvement. Variations in implant design persist whether the patella is resurfaced or not. Implant selection and patellar resurfacing may be associated with patient outcomes.
关节成形术登记处报告了翻修风险,但患者报告的结局也可衡量植入物的性能。我们旨在评估:(i)区域登记处中多种全膝关节置换术(TKA)设计的患者报告结局测量指标(PROMs)的变化;(ii)髌骨表面置换对PROMs变化的影响;(iii)有无髌骨表面置换的植入物中PROMs变化的差异。
这是一组来自密歇根关节成形术登记协作质量倡议(MARCQI)的初次TKA病例,手术时间为2017年1月1日至2021年9月30日。因变量是KOOS JR的变化。自变量是植入物名称和髌骨表面置换情况。多变量模型对患者层面的因素进行了调整。之前的一份报告表明,KOOS JR变化23分在临床上与达到可接受的疼痛/功能水平相关。计算了每种植入物达到23分阈值的患者与总体患者的临床相关性比率(CRR)。
18种植入物设计符合纳入标准。有51,606例术前和术后KOOS JR配对完整的病例。不同植入物设计的术前至术后未经调整的KOOS JR评分改善情况存在差异(P<0.001),范围从18.7(95%置信区间[CI]16.8 - 20.6)到27.0(CI 24.9 - 29.2)。髌骨表面置换使KOOS JR改善更大,为1.0(CI 0.5 - 1.5,P<0.001)。在髌骨表面置换的病例中,CRR为50.2%(CI 49.7 - 50.7)。对于未进行髌骨表面置换的病例,CRR为47.2%(CI 45.9 - 48.5)。无论髌骨是否进行表面置换,植入物设计的关联均持续存在,在调整后的KOOS JR平均变化中很明显(P<0.001),髌骨表面置换的范围为20.1(CI 17.6 - 22.6)至25.5(CI 24.3 - 26.7),未进行表面置换的范围为17.0(CI 13.9 - 20.1)至23.3(CI 20.3 - 26.2),CRR差异也很明显(P<0.001),髌骨表面置换的范围为45.8%(CI 42.5 - 48.6)至55.8%(CI 50.4 - 60.8),未进行表面置换的范围为37.9%(CI 27.4 - 44.7)至51.4%(CI 43.9 - 56.6)。
植入物设计和髌骨表面置换均与KOOS JR的改善相关。无论髌骨是否进行表面置换,植入物设计的差异均持续存在。植入物的选择和髌骨表面置换可能与患者结局相关。